Skip to main content

FMC Corporation (FMC)

Stock NYSE

$3.89

-0.40 (-9.32%)

Delayed quote.

Price history

Daily close
FMC daily closing price, Nov 24, 2025 to Nov 20, 2026 Closed at $13.18 on Nov 24, 2025 and $3.90 on Nov 20, 2026, a change of -70.41%. Range $3.90 to $18.07.
Daily closes, Nov 24, 2025 to Nov 20, 2026 (250 trading days).
Start
$13.18
Latest close
$3.90
Period change
-70.41%
Period low
$3.90
Period high
$18.07

Key metrics

Market cap
$487.13M
Volume
6.25M
Average volume
5.37M
52-week range
$3.89 – $18.29
Beta
0.50
Last dividend
$0.32
EPS (TTM)
-$33.04
P/E ratio
-0.78
Revenue (TTM)
$2.87B
Net income (TTM)
-$4.26B
Total assets
$7.91B
Total debt
$4.30B
Cash and equivalents
$735.80M

Key financials (trailing twelve months).

Company profile

FMC Corporation functions as an agricultural science enterprise, delivering products for crop safeguarding, plant wellness, and professional pest and turf management. The company is responsible for creating, commercializing, and selling various crop protection chemicals, including insecticides, herbicides, and fungicides, alongside biologicals, crop nutrition supplements, and seed treatment solutions. These innovations are employed in farming to boost harvest quantity and quality by mitigating diverse insect infestations, weed growth, and plant ailments. Furthermore, its solutions cater to non-agricultural sectors for general pest control. FMC distributes its comprehensive product range through its proprietary sales teams, in collaboration with alliance partners, and via independent distributors and sales representatives. Established in 1883, FMC Corporation is based in Philadelphia, Pennsylvania, and conducts operations across North America, Latin America, Europe, the Middle East, Africa, and Asia.

Sector
Basic Materials
Industry
Agricultural Inputs
Exchange
NYSE
CEO
Pierre R. Brondeau
Employees
5,500
Headquarters
Philadelphia, PA, US
IPO date
1980-03-17

Financial statements

Annual, last 3 fiscal years. Most recent period first. Reported in USD.

Income statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Revenue$3.47B$4.25B$4.49B
Gross profit$1.28B$1.58B$1.91B
Operating income-$1.89B$654.70M$837.90M
EBITDA-$84.70M$662.70M$786.20M
Net income-$2.24B$339.90M$1.32B
Diluted EPS-$17.88$2.72$10.51
Balance sheet
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Cash and equivalents$584.50M$357.30M$302.40M
Total assets$9.69B$11.65B$11.93B
Total liabilities$7.59B$7.14B$7.49B
Total debt$4.20B$3.50B$4.11B
Shareholders’ equity$2.07B$4.49B$4.41B
Cash flow statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Operating cash flow-$80.20M$671.10M-$386.40M
Capital expenditure-$96.30M-$67.90M-$133.90M
Free cash flow-$176.50M$603.20M-$520.30M

Quarterly, last 6 quarters. Most recent period first. Reported in USD.

Income statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Revenue$105.90M$867.10M$758.60M$1.14B$489.00M$1.05B
Gross profit-$401.60M$342.10M$246.60M$483.00M$75.70M$407.30M
Operating income-$631.60M-$119.70M-$81.00M-$1.66B-$467.30M$164.10M
EBITDA-$590.70M-$81.90M-$42.40M$96.00M-$358.50M$162.70M
Net income-$2.07B-$186.60M-$281.30M-$1.72B-$569.30M$66.70M
Diluted EPS-$15.54-$1.48-$2.25-$13.77-$4.52$0.53
Balance sheet
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Cash and equivalents$735.80M$476.60M$390.90M$584.50M$497.70M$438.20M
Total assets$7.91B$9.14B$9.42B$9.69B$12.08B$12.30B
Total liabilities$7.90B$7.48B$7.57B$7.59B$8.28B$7.87B
Total debt$4.30B$4.28B$4.66B$4.20B$4.54B$4.16B
Shareholders’ equity-$19.40M$1.64B$1.82B$2.07B$3.77B$4.40B
Cash flow statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Operating cash flow-$13.30M$328.70M-$616.60M$636.80M-$208.20M$49.50M
Capital expenditure-$7.80M-$5.30M-$16.60M-$26.00M-$23.70M-$15.00M
Free cash flow-$21.10M$323.40M-$633.20M$610.80M-$231.90M$34.50M